Inhibitory Potential of Resveratrol in Cancer Metastasis: From Biology to Therapy

Simple Summary The majority of cancer-related deaths are attributed to metastatic tumors, making the inhibition of cancer metastasis a critical challenge in cancer treatment. Resveratrol, a compound first reported in 1997 to have anticancer properties, has shown potential in suppressing cancer metastasis in preclinical studies. Despite these positive results, clinical trials have yielded limited progress so far, highlighting the need to understand the cellular processes and signaling pathways involved in resveratrol’s anticancer activity against metastatic tumors. This review article summarizes the past five years’ research on resveratrol’s potential in cancer prevention or therapy and signaling pathways in inhibiting cancer metastasis and evaluates its bioavailability and toxicity. We also discuss the challenges of using resveratrol as an anticancer drug candidate and the current animal models used for preclinical studies. Overall, this article provides valuable insights into the development of resveratrol as an antimetastatic drug for cancer therapy. Abstract Cancer metastasis is a significant challenge in cancer treatment, and most existing drugs are designed to inhibit tumor growth but are often ineffective in treating metastatic cancer, which is the leading cause of cancer-related deaths. Resveratrol, a polyphenol found in grapes, berries, and peanuts, has shown potential in preclinical studies as an anticancer agent to suppress metastasis. However, despite positive results in preclinical studies, little progress has been made in clinical trials. To develop resveratrol as an effective anticancer agent, it is crucial to understand its cellular processes and signaling pathways in tumor metastasis. This review article evaluates the current state and future development strategies of resveratrol to enhance its potency against cancer metastasis within its therapeutic dose. In addition, we critically evaluate the animal models used in preclinical studies for cancer metastasis and discuss novel techniques to accelerate the translation of resveratrol from bench to bedside. The appropriate selection of animal models is vital in determining whether resveratrol can be further developed as an antimetastatic drug in cancer therapy.

[1]  A. Jemal,et al.  Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[2]  Jia Wang,et al.  Resveratrol Reverses TGF-β1–Mediated Invasion and Metastasis of Breast Cancer Cells Via the SIRT3/AMPK/Autophagy Signal Axis , 2021, SSRN Electronic Journal.

[3]  J. Zou,et al.  Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway , 2022, Clinical and Translational Oncology.

[4]  Hong Li,et al.  Resveratrol Downregulates miR-155-5p to Block the Malignant Behavior of Gastric Cancer Cells , 2022, BioMed research international.

[5]  Zhuying Yang,et al.  Resveratrol inhibits the proliferation, invasion, and migration, and induces the apoptosis of human gastric cancer cells through the MALAT1/miR-383-5p/DDIT4 signaling pathway. , 2022, Journal of gastrointestinal oncology.

[6]  Manuel Valenzuela-Valderrama,et al.  Resveratrol Decreases the Invasion Potential of Gastric Cancer Cells , 2022, Molecules.

[7]  Andrea Esposito,et al.  Resveratrol Contrasts IL-6 Pro-Growth Effects and Promotes Autophagy-Mediated Cancer Cell Dormancy in 3D Ovarian Cancer: Role of miR-1305 and of Its Target ARH-I , 2022, Cancers.

[8]  Ø. Bruland,et al.  Early immunohistochemical detection of pulmonary micrometastases in dogs with osteosarcoma , 2021, Acta Veterinaria Scandinavica.

[9]  Andrea Esposito,et al.  Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy , 2021, Cells.

[10]  T. Lange,et al.  Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment , 2021, Cancers.

[11]  Wenyan Wang,et al.  Upregulation of MicroRNA-34a Sensitizes Ovarian Cancer Cells to Resveratrol by Targeting Bcl-2 , 2021, Yonsei medical journal.

[12]  B. Goh,et al.  Resveratrol for cancer therapy: Challenges and future perspectives. , 2021, Cancer letters.

[13]  Jai-Sing Yang,et al.  Resveratrol inhibited the metastatic behaviors of cisplatin-resistant human oral cancer cells via phosphorylation of ERK/p-38 and suppression of MMP-2/9. , 2021, Journal of food biochemistry.

[14]  B. Goh,et al.  Extracellular vesicles, the cornerstone of next-generation cancer diagnosis? , 2021, Seminars in cancer biology.

[15]  R. Weinberg,et al.  Linking EMT programmes to normal and neoplastic epithelial stem cells , 2021, Nature Reviews Cancer.

[16]  T. Rachner,et al.  The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone , 2021, International journal of molecular sciences.

[17]  P. Papageorgis,et al.  The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities , 2021, Cancers.

[18]  J. Meyer-Fernandes,et al.  Resveratrol is an inhibitor of sodium‐dependent inorganic phosphate transport in triple‐negative MDA‐MB‐231 breast cancer cells , 2021, Cell biology international.

[19]  T. Ochiya,et al.  Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology. , 2021, Seminars in cancer biology.

[20]  Theresa Akoto,et al.  Role of Exosomes in Prostate Cancer Metastasis , 2021, International journal of molecular sciences.

[21]  M. Mandal,et al.  Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages. , 2021, The Journal of nutritional biochemistry.

[22]  Cheng Peng,et al.  Panax ginseng and its ginsenosides: potential candidates for the prevention and treatment of chemotherapy-induced side effects , 2021, Journal of ginseng research.

[23]  K. Brown,et al.  Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a “dietary-achievable” or “pharmacological” dose: what are the implications for anticancer activity? , 2021, The American journal of clinical nutrition.

[24]  Yue Xiao,et al.  Resveratrol suppresses malignant progression of oral squamous cell carcinoma cells by inducing the ZNF750/RAC1 signaling pathway , 2021, Bioengineered.

[25]  C. Vanhove,et al.  In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis , 2020, PloS one.

[26]  Ted E. Natoli,et al.  A metastasis map of human cancer cell lines , 2020, Nature.

[27]  M. Kamal,et al.  A critical transcription factor NF-κB as a cancer therapeutic target and its inhibitors as cancer treatment options. , 2020, Current medicinal chemistry.

[28]  Daniel Xin Zhang,et al.  Extracellular vesicle‐associated organotropic metastasis , 2020, Cell proliferation.

[29]  Xiaodong Sun,et al.  Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3Tyr705 phosphorylation , 2020, Cancer medicine.

[30]  G. Nagaraju,et al.  Resveratrol binds and activates RKIP protein in colorectal cancer , 2020, Amino Acids.

[31]  M. Shakibaei,et al.  Resveratrol Suppresses Cross-Talk between Colorectal Cancer Cells and Stromal Cells in Multicellular Tumor Microenvironment: A Bridge between In Vitro and In Vivo Tumor Microenvironment Study , 2020, Molecules.

[32]  Jiancheng Hu,et al.  The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy , 2020, Journal of Hematology & Oncology.

[33]  Dirk Sieger,et al.  Zebrafish In Vivo Models of Cancer and Metastasis. , 2020, Cold Spring Harbor perspectives in medicine.

[34]  K. Ahn,et al.  Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities , 2020, Biomedicines.

[35]  L. Yin,et al.  Gastric-cancer-derived mesenchymal stem cells: a promising target for resveratrol in the suppression of gastric cancer metastasis , 2020, Human Cell.

[36]  Xuqi Li,et al.  Resveratrol Counteracts Hypoxia-Induced Gastric Cancer Invasion and EMT through Hedgehog Pathway Suppression. , 2020, Anti-cancer agents in medicinal chemistry.

[37]  Weinan Pan,et al.  miR-139-mediated NOTCH1 regulation is crucial for the inhibition of osteosarcoma progression caused by resveratrol. , 2019, Life sciences.

[38]  Farjana Yeasmin Khusbu,et al.  Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration. , 2019, The international journal of biochemistry & cell biology.

[39]  Saugata Hazra,et al.  The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective , 2019, Journal of cellular physiology.

[40]  T. Kisková,et al.  Resveratrol Action on Lipid Metabolism in Cancer , 2019, International journal of molecular sciences.

[41]  J. Espín,et al.  Metabolic Profiling of Dietary Polyphenols and Methylxanthines in Normal and Malignant Mammary Tissues from Breast Cancer Patients. , 2019, Molecular nutrition & food research.

[42]  M. Shakibaei,et al.  Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol , 2019, Nutrients.

[43]  C. Blanpain,et al.  EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.

[44]  M. Shakibaei,et al.  Evidence that TNF-β induces proliferation in colorectal cancer cells and resveratrol can down-modulate it , 2019, Experimental biology and medicine.

[45]  Y. Liu,et al.  TGF-β1 induces epithelial-to-mesenchymal transition via inhibiting mitochondrial functions in A549 cells , 2018, Free radical research.

[46]  Yan Luo,et al.  Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway , 2018, Journal of cellular biochemistry.

[47]  Yuyang Sun,et al.  TGFβ‐induced epithelial‐to‐mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression , 2018, Molecular carcinogenesis.

[48]  Tingting Yang,et al.  Resveratrol inhibits Interleukin-6 induced invasion of human gastric cancer cells. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[49]  Jianjun Liu,et al.  Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[50]  G. Rosner,et al.  Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial , 2017, Clinical Cancer Research.

[51]  Binzhi Qian.  Inflammation fires up cancer metastasis. , 2017, Seminars in cancer biology.

[52]  Euan J. Rodger,et al.  Epigenetic drivers of tumourigenesis and cancer metastasis. , 2017, Seminars in cancer biology.

[53]  Shaker A. Mousa,et al.  The Role of Angiogenesis in Cancer Treatment , 2017, Biomedicines.

[54]  B. Carneiro,et al.  Wnt/beta-catenin pathway: modulating anticancer immune response , 2017, Journal of Hematology & Oncology.

[55]  J. Espinoza,et al.  The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans , 2017, Oxidative medicine and cellular longevity.

[56]  Jeremy MG Taylor,et al.  A Placebo‐Controlled Double‐Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer , 2017, The Prostate.

[57]  Jing Yang,et al.  Epithelial–mesenchymal transition in tumor metastasis , 2016, Molecular oncology.

[58]  Kebin Liu,et al.  An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis. , 2016, Journal of visualized experiments : JoVE.

[59]  G. M. Fávero,et al.  Resveratrol-loaded nanocapsules inhibit murine melanoma tumor growth. , 2016, Colloids and surfaces. B, Biointerfaces.

[60]  N. Kosaka,et al.  Versatile roles of extracellular vesicles in cancer. , 2016, The Journal of clinical investigation.

[61]  D. Chan,et al.  Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges. , 2016, Acta biochimica et biophysica Sinica.

[62]  Wen-Wei Hu,et al.  Tumor-associated macrophages in cancers , 2016, Clinical and Translational Oncology.

[63]  Yihai Cao,et al.  Resveratrol analogue 4,4′-dihydroxy-trans-stilbene potently inhibits cancer invasion and metastasis , 2016, Scientific Reports.

[64]  G. Rosner,et al.  A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination , 2015, The Prostate.

[65]  L. Howells,et al.  Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice , 2015, Science Translational Medicine.

[66]  B. Zetter,et al.  The Contribution of Angiogenesis to the Process of Metastasis. , 2015, Cancer journal.

[67]  R. Holcombe,et al.  Effects of a grape-supplemented diet on proliferation and Wnt signaling in the colonic mucosa are greatest for those over age 50 and with high arginine consumption , 2015, Nutrition Journal.

[68]  R. Linding,et al.  The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase , 2015, Nature.

[69]  P. Lockhart,et al.  An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels , 2015, Journal of Neurology.

[70]  Sachin S Thakur,et al.  Resveratrol nanoformulations: challenges and opportunities. , 2015, International journal of pharmaceutics.

[71]  M. Cekanova,et al.  Animal models and therapeutic molecular targets of cancer: utility and limitations , 2014, Drug design, development and therapy.

[72]  Chiu-Hsieh Hsu,et al.  A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones , 2014, Journal of Translational Medicine.

[73]  A. Puisieux,et al.  Oncogenic roles of EMT-inducing transcription factors , 2014, Nature Cell Biology.

[74]  R. Carpenter,et al.  STAT3 Target Genes Relevant to Human Cancers , 2014, Cancers.

[75]  Ji-Hong Liu,et al.  Large animal model for retroperitoneal lymphatic and lung metastasis , 2013, Molecular medicine reports.

[76]  Kathrine B. Christensen,et al.  Semi-preparative isolation of dihydroresveratrol-3-O-β-d-glucuronide and four resveratrol conjugates from human urine after oral intake of a resveratrol-containing dietary supplement. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[77]  Mingyao Liu,et al.  Zebrafish cancer and metastasis models for in vivo drug discovery. , 2013, Drug discovery today. Technologies.

[78]  I. Kapetanovic.  Comment on 'Resveratrol in human cancer chemoprevention--choosing the 'right' dose'. , 2012, Molecular Nutrition & Food Research.

[79]  liyan Huang,et al.  Establishment of an orthotopic lung cancer model in nude mice and its evaluation by spiral CT. , 2012, Journal of thoracic disease.

[80]  G. Rottinghaus,et al.  Trans-Resveratrol Alters Mammary Promoter Hypermethylation in Women at Increased Risk for Breast Cancer , 2012, Nutrition and cancer.

[81]  D. Du,et al.  Current separative strategies used for resveratrol determination from natural sources , 2011 .

[82]  Holger Gerhardt,et al.  Basic and Therapeutic Aspects of Angiogenesis , 2011, Cell.

[83]  P. Elliott,et al.  Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases—Safety, Pharmacokinetics, and Pharmacodynamics , 2011, Cancer Prevention Research.

[84]  T. Walle.  Bioavailability of resveratrol , 2011, Annals of the New York Academy of Sciences.

[85]  Ananda Sen,et al.  Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. , 2010, Cancer research.

[86]  Donald J L Jones,et al.  Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. , 2010, Cancer research.

[87]  Jessica A. Miller,et al.  Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study , 2010, Cancer Prevention Research.

[88]  S. Alahari,et al.  miRNA control of tumor cell invasion and metastasis , 2010, International journal of cancer.

[89]  N. Northrup,et al.  Prostate cancer in dogs: comparative and clinical aspects. , 2009, Veterinary journal.

[90]  A. Falcão,et al.  Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. , 2009, Molecular nutrition & food research.

[91]  R. Holcombe,et al.  Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer , 2009, Cancer management and research.

[92]  J. Pollard.  Trophic macrophages in development and disease , 2009, Nature Reviews Immunology.

[93]  Chao Yan,et al.  Analysis of trans-Resveratrol in Grapes by Micro-High Performance Liquid Chromatography , 2008, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[94]  R. Medzhitov.  Origin and physiological roles of inflammation , 2008, Nature.

[95]  J. Crowell,et al.  Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent , 2007, Cancer Epidemiology Biomarkers & Prevention.

[96]  Ramon Mangues,et al.  Tumorigenesis and Neoplastic Progression Orthotopic Microinjection of Human Colon Cancer Cells in Nude Mice Induces Tumor Foci in All Clinically Relevant Metastatic Sites , 2007 .

[97]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[98]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[99]  Weizhen He,et al.  [Study on the preparation of resveratrol chitosan nanoparticles with free amino groups on the surface]. , 2006, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[100]  V. Somoza,et al.  Metabolism and bioavailability of trans-resveratrol. , 2005, Molecular nutrition & food research.

[101]  T. Walle,et al.  HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS , 2004, Drug Metabolism and Disposition.

[102]  M. Mergeay,et al.  Enhanced radiation-induced apoptosis of cancer cell lines after treatment with resveratrol. , 2004, International journal of molecular medicine.

[103]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[104]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[105]  Y. Kimura,et al.  Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. , 2001, Journal of NutriLife.

[106]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[107]  I. Fidler,et al.  In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. , 1988, Cancer research.

[108]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[109]  S. Nonomura,et al.  [CHEMICAL CONSTITUENTS OF POLYGONACEOUS PLANTS. I. STUDIES ON THE COMPONENTS OF KO-J O-KON. (POLYGONUM CUSPIDATUM SIEB. ET ZUCC.)]. , 1963, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[110]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[111]  F. Marincola,et al.  The Tumor Microenvironment , 2016, Methods in Molecular Biology.

[112]  R. Lakshmanaswamy,et al.  Cancer Stem Cells and Metastasis. , 2017, Progress in molecular biology and translational science.

[113]  G. van der Pluijm,et al.  A zebrafish xenograft model for studying human cancer stem cells in distant metastasis and therapy response. , 2017, Methods in cell biology.

[114]  D. Dhawan,et al.  Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development. , 2014, ILAR journal.